Sight Sciences, Inc. (SGHT): restructuring charge — Sight Sciences cuts 20% workforce; CCO departs; reaffirms FY revenue guidance

Sight Sciences, Inc.

Reduces headcount by 43 (~20% of global workforce); expects cash restructuring charge of $2.7M-$3.0M in Q3 2025.
CCO Matthew Link steps down effective Aug 31; eligible for severance including 1-year base salary and vesting of 61,675 RSUs.
Reaffirms FY2025 revenue guidance of $72M-$76M; updates adjusted opex guidance to $95M-$99M from $101M-$105M.
Annualized savings of ~$11.9M from workforce reductions alone.
Creates segment-specific leadership for Surgical Glaucoma and Dry Eye; delays certain R&D spend.

Key facts

Extracted from this filing and checked against the source text.

Restructurings & Charges SEC 8-K Item 2.05/2.06 confidence 0.95

Sight Sciences, Inc. announced a restructuring with charges of cash restructuring charge of approximately $2.7 million to $3.0 million primarily in the third quarter of 2025, consisting mostly of one-time employee severance affecting global operations, with specific changes in the United Kingdom (reduce its headcount by 43 employees, or approximately 20% of its global workforce, including up to four UK-based employ).

Type: restructuring
Charge: cash restructuring charge of approximately $2.7 million to $3.0 million primarily in the third quarter of 2025, consisting mostly of one-time employee severance
Affected area: global operations, with specific changes in the United Kingdom
Headcount: reduce its headcount by 43 employees, or approximately 20% of its global workforce, including up to four UK-based employ

Exact text from the filing

On August 27, 2025, Sight Sciences, Inc. (the “Company”) informed its employees that it is implementing a targeted plan, commencing immediately, intended to reduce operating expenses, improve cost efficiencies, and better align its operating structure for long-term, profitable growth (the “Plan”).

View on SEC.gov

6 restructurings & charges filed in the last 30 days. Browse all restructurings & charges →

Sight Sciences, Inc. filing history →

Source: SEC EDGAR

accession 0001531177-25-000007

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.